{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:44:13Z","timestamp":1792021453563,"version":"4.4.0"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bcp.2026.118533","type":"journal-article","created":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T22:07:47Z","timestamp":1791756467000},"page":"118533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P3","title":["Isoform differentiation studies of arginase: From structural function to design strategies for specific ligands and their application prospects"],"prefix":"10.1016","volume":"254","author":[{"given":"Chang","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Han","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1156-4162","authenticated-orcid":false,"given":"Li-Wei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118533_b0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0167-4838(97)00131-3","article-title":"Roles of conserved residues in the arginase family","volume":"1382","author":"Perozich","year":"1998","journal-title":"Biochim. Biophys. Acta Protein Struct. Mol. Enzymol."},{"key":"10.1016\/j.bcp.2026.118533_b0010","doi-asserted-by":"crossref","first-page":"2760S","DOI":"10.1093\/jn\/134.10.2760S","article-title":"Structure and Function of Arginases","volume":"134","author":"Ash","year":"2004","journal-title":"J. Nutr."},{"key":"10.1016\/j.bcp.2026.118533_b0015","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-3-030-74180-8_10","article-title":"Role of L-arginine in nitric oxide synthesis and health in humans","volume":"1332","author":"Wu","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"issue":"6 Suppl 2","key":"10.1016\/j.bcp.2026.118533_b0020","doi-asserted-by":"crossref","first-page":"1602S","DOI":"10.1093\/jn\/137.6.1602S","article-title":"Arginine metabolism: boundaries of our knowledge","volume":"137","author":"Morris","year":"2007","journal-title":"J. Nutr."},{"issue":"1","key":"10.1016\/j.bcp.2026.118533_b0025","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41420-022-01200-4","article-title":"Arginase: shedding light on the mechanisms and opportunities in cardiovascular diseases","volume":"8","author":"Li","year":"2022","journal-title":"Cell Death Discovery"},{"issue":"6","key":"10.1016\/j.bcp.2026.118533_b0030","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.tips.2015.03.006","article-title":"Arginase: an old enzyme with new tricks","volume":"36","author":"Caldwell","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2026.118533_b0035","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000096","article-title":"Arginase-II induces vascular smooth muscle cell senescence and apoptosis through p66Shc and p53 independently of its L-arginine ureahydrolase activity: implications for atherosclerotic plaque vulnerability","volume":"2","author":"Xiong","year":"2013","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.bcp.2026.118533_b0040","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0006-291X(86)80333-3","article-title":"Isolation of human liver arginase cDNA and demonstration of nonhomology between the two human arginase genes","volume":"141","author":"Dizikes","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.bcp.2026.118533_b0045","first-page":"186","article-title":"The human gene for liver arginase (ARG1) is assigned to chromosome 6","volume":"73","author":"Sparkes","year":"1986","journal-title":"Hum. Genet."},{"issue":"2","key":"10.1016\/j.bcp.2026.118533_b0050","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1006\/geno.1996.0606","article-title":"Cloning and characterization of the human type II arginase gene","volume":"38","author":"Vockley","year":"1996","journal-title":"Genomics"},{"issue":"22","key":"10.1016\/j.bcp.2026.118533_b0055","doi-asserted-by":"crossref","first-page":"19988","DOI":"10.1021\/acs.jmedchem.4c01429","article-title":"Structural and dynamic insights into the arginase isoforms: implications for selective inhibitor design","volume":"67","author":"Failla","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2026.118533_b0060","doi-asserted-by":"crossref","unstructured":"Di Costanzo, L.; Sabio, G.; Mora, A.; Rodriguez, P. C.; Ochoa, A. C.; Centeno, F.; Christianson, D. W. Crystal structure of human arginase I at 1.29-\u00c5 resolution and exploration of inhibition in the immune response. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(37): 13058-13063.","DOI":"10.1073\/pnas.0504027102"},{"key":"10.1016\/j.bcp.2026.118533_b0065","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev.nutr.22.110801.140547","article-title":"Regulation of enzymes of the urea cycle and arginine metabolism","volume":"22","author":"Morris","year":"2002","journal-title":"Annu. Rev. Nutr."},{"issue":"13","key":"10.1016\/j.bcp.2026.118533_b0070","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1128\/MCB.22.13.4491-4498.2002","article-title":"Mouse model for human arginase deficiency","volume":"22","author":"Iyer","year":"2002","journal-title":"Mol. Cell. Biol."},{"issue":"2\u20133","key":"10.1016\/j.bcp.2026.118533_b0075","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0014-5793(96)01015-0","article-title":"Molecular cloning of cDNA for nonhepatic mitochondrial arginase (arginase II) and comparison of its induction with nitric oxide synthase in a murine macrophage-like cell line","volume":"395","author":"Gotoh","year":"1996","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.bcp.2026.118533_b0080","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2020.1801230","article-title":"Structural and functional characterization of C0021158, a high-affinity monoclonal antibody that inhibits Arginase 2 function via a novel non-competitive mechanism of action","volume":"12","author":"Austin","year":"2020","journal-title":"MAbs"},{"issue":"6600","key":"10.1016\/j.bcp.2026.118533_b0085","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/383554a0","article-title":"Structure of a unique binuclear manganese cluster in arginase","volume":"383","author":"Kanyo","year":"1996","journal-title":"Nature"},{"issue":"28","key":"10.1016\/j.bcp.2026.118533_b0090","doi-asserted-by":"crossref","first-page":"8445","DOI":"10.1021\/bi034340j","article-title":"Human arginase II: crystal structure and physiological role in male and female sexual arousal","volume":"42","author":"Cama","year":"2003","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.bcp.2026.118533_b0095","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1021\/ar040183k","article-title":"Arginase: structure, mechanism, and physiological role in male and female sexual arousal","volume":"38","author":"Christianson","year":"2005","journal-title":"Acc. Chem. Res."},{"issue":"23","key":"10.1016\/j.bcp.2026.118533_b0100","doi-asserted-by":"crossref","first-page":"8539","DOI":"10.1021\/bi972874c","article-title":"L-Arginine binding to liver arginase requires proton transfer to gateway residue His141 and stabilization of a salt bridge between Asp128 and Mn2+_A","volume":"37","author":"Khangulov","year":"1998","journal-title":"Biochemistry"},{"issue":"43","key":"10.1016\/j.bcp.2026.118533_b0105","doi-asserted-by":"crossref","first-page":"13052","DOI":"10.1021\/ja036365b","article-title":"Design of amino acid sulfonamides as transition-state analogue inhibitors of arginase","volume":"125","author":"Cama","year":"2003","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.bcp.2026.118533_b0110","article-title":"Insights on the participation of Glu256 and Asp204 in the oligomeric structure and cooperative effects of human arginase type I","volume":"212","author":"Lobos","year":"2020","journal-title":"J. Struct. Biol."},{"issue":"13","key":"10.1016\/j.bcp.2026.118533_b0115","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1093\/cvr\/cvx164","article-title":"Obesity-induced vascular dysfunction and arterial stiffening requires endothelial cell arginase 1","volume":"113","author":"Bhatta","year":"2017","journal-title":"Cardiovasc. Res."},{"issue":"20","key":"10.1016\/j.bcp.2026.118533_b0120","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1021\/ja071567j","article-title":"Crystal structure of human arginase I complexed with thiosemicarbazide reveals an unusual thiocarbonyl \u03bc-sulfide ligand in the binuclear manganese cluster","volume":"129","author":"Di Costanzo","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bcp.2026.118533_b0125","doi-asserted-by":"crossref","first-page":"938","DOI":"10.3389\/fimmu.2020.00938","article-title":"Myeloid Cell-Derived Arginase in Cancer Immune Response","volume":"11","author":"Grzywa","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118533_b0130","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/CIRCRESAHA.115.304262","article-title":"OxLDL triggers retrograde translocation of arginase2 in aortic endothelial cells via ROCK and mitochondrial processing peptidase","volume":"115","author":"Pandey","year":"2014","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.bcp.2026.118533_b0135","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/oxfordjournals.jbchem.a022036","article-title":"Mitochondria-targeting sequence, a multi-role sorting sequence recognized at all steps of protein import into mitochondria","volume":"123","author":"Omura","year":"1998","journal-title":"J. Biochem."},{"key":"10.1016\/j.bcp.2026.118533_b0140","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1146\/annurev.biochem.76.052705.163409","article-title":"Translocation of proteins into mitochondria","volume":"76","author":"Neupert","year":"2007","journal-title":"Annu. Rev. Biochem"},{"issue":"34","key":"10.1016\/j.bcp.2026.118533_b0145","doi-asserted-by":"crossref","first-page":"10558","DOI":"10.1021\/bi970800v","article-title":"Altering the binuclear manganese cluster of arginase diminishes thermostability and catalytic function","volume":"36","author":"Scolnick","year":"1997","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.bcp.2026.118533_b0150","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1021\/cb900267j","article-title":"Replacing Mn2+ with Co2+ in human arginase I enhances cytotoxicity toward L-arginine auxotrophic cancer cell lines","volume":"5","author":"Stone","year":"2010","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bcp.2026.118533_b0155","first-page":"1170","article-title":"A comparative study of the catalytic activity of human arginase I with Mn2+ and Co2+ metal ions","volume":"148","author":"Chung","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118533_b0160","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0003-9861(02)00204-7","article-title":"Insights into the interaction of human liver arginase with tightly and weakly bound manganese ions by chemical modification and site-directed mutagenesis studies","volume":"403","author":"Orellana","year":"2002","journal-title":"Arch. Biochem. Biophys."},{"issue":"42","key":"10.1016\/j.bcp.2026.118533_b0165","doi-asserted-by":"crossref","first-page":"8399","DOI":"10.1021\/bi301145n","article-title":"Structure and function of non-native metal clusters in human arginase I","volume":"51","author":"D'Antonio","year":"2012","journal-title":"Biochemistry"},{"issue":"17","key":"10.1016\/j.bcp.2026.118533_b0170","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1111\/j.1742-4658.2005.04874.x","article-title":"Insights into the interaction of human arginase II with substrate and manganese ions by site-directed mutagenesis and kinetic studies","volume":"272","author":"L\u00f3pez","year":"2005","journal-title":"FEBS J."},{"issue":"8","key":"10.1016\/j.bcp.2026.118533_b0175","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.jinorgbio.2004.05.005","article-title":"Non-chelating inhibition of manganese-containing arginase by borate","volume":"98","author":"Carvajal","year":"2004","journal-title":"J. Inorg. Biochem."},{"issue":"1","key":"10.1016\/j.bcp.2026.118533_b0180","first-page":"1","article-title":"An enzyme cascade with horseradish peroxidase readout for high-throughput screening and engineering of human arginase-1","volume":"8","author":"Fern\u00e1ndez de Santaella","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2026.118533_b0185","doi-asserted-by":"crossref","first-page":"E75","DOI":"10.1152\/ajpendo.2001.280.1.E75","article-title":"Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells","volume":"280","author":"Li","year":"2001","journal-title":"American Journal of Physiology-Endocrinology and Metabolism"},{"key":"10.1016\/j.bcp.2026.118533_b0190","doi-asserted-by":"crossref","first-page":"13616","DOI":"10.1038\/s41598-017-13366-4","article-title":"Arginase Structure and Inhibition: Catalytic Site Plasticity reveals New Modulation Possibilities","volume":"7","author":"Mortier","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bcp.2026.118533_b0195","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/cvr\/cvt036","article-title":"Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal?","volume":"98","author":"Pernow","year":"2013","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"10.1016\/j.bcp.2026.118533_b0200","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1182\/blood-2004-07-2521","article-title":"Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity","volume":"105","author":"Munder","year":"2005","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bcp.2026.118533_b0205","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1182\/blood-2006-11-010389","article-title":"Suppression of T-cell functions by human granulocyte arginase","volume":"108","author":"Munder","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bcp.2026.118533_b0210","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1096-7192(02)00034-3","article-title":"Expression of the liver form of arginase in erythrocytes","volume":"76","author":"Kim","year":"2002","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.bcp.2026.118533_b0215","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0378-1119(97)00099-1","article-title":"Human type II arginase: sequence analysis and tissue-specific expression","volume":"193","author":"Morris","year":"1997","journal-title":"Gene"},{"issue":"11","key":"10.1016\/j.bcp.2026.118533_b0220","first-page":"e1525","article-title":"Arginase 2 deletion reduces hyperoxia-mediated retinal neurodegeneration through the regulation of polyamine metabolism","volume":"5","author":"Narayanan","year":"2014","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.bcp.2026.118533_b0225","first-page":"553","article-title":"p38 mitogen-activated protein kinase is involved in arginase-II-mediated eNOS-uncoupling in endothelial cells","volume":"97","author":"Yu","year":"2013","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.bcp.2026.118533_b0230","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1369\/jhc.4A6489.2005","article-title":"Mitochondrial expression of arginase II in male and female rat inner medullary collecting ducts","volume":"53","author":"Levillain","year":"2005","journal-title":"Journal of Histochemistry & Cytochemistry"},{"issue":"5","key":"10.1016\/j.bcp.2026.118533_b0235","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.immuni.2010.05.007","article-title":"Alternative activation of macrophages: mechanism and functions","volume":"32","author":"Gordon","year":"2010","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.bcp.2026.118533_b0240","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.bcp.2026.118533_b0245","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.000992","article-title":"Arginase II promotes macrophage inflammatory responses through mitochondrial reactive oxygen species, contributing to insulin resistance and atherogenesis","volume":"1","author":"Ming","year":"2012","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.bcp.2026.118533_b0250","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1152\/physrev.00037.2016","article-title":"Arginase: a multifaceted enzyme important in health and disease","volume":"98","author":"Caldwell","year":"2018","journal-title":"Physiol. Rev."},{"issue":"7","key":"10.1016\/j.bcp.2026.118533_b0255","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: regulation and function","volume":"33","author":"F\u00f6rstermann","year":"2012","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.bcp.2026.118533_b0260","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1152\/japplphysiol.91393.2008","article-title":"Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats","volume":"107","author":"Kim","year":"2009","journal-title":"J. Appl. Physiol."},{"issue":"7","key":"10.1016\/j.bcp.2026.118533_b0265","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/CIRCRESAHA.107.157727","article-title":"Inducible NO synthase dependent S-nitrosylation and activation of arginase1 contribute to age-related endothelial dysfunction","volume":"101","author":"Santhanam","year":"2007","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.bcp.2026.118533_b0270","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1152\/japplphysiol.90627.2008","article-title":"Arginase and vascular aging","volume":"105","author":"Santhanam","year":"2008","journal-title":"J. Appl. Physiol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118533_b0275","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.bbrc.2011.09.112","article-title":"Intracellular l-arginine concentration does not determine NO production in endothelial cells: Implications on the \u201cl-arginine paradox\u201d","volume":"414","author":"Shin","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6 Suppl 2","key":"10.1016\/j.bcp.2026.118533_b0280","doi-asserted-by":"crossref","first-page":"1616S","DOI":"10.1093\/jn\/137.6.1616S","article-title":"Regulation of nitric oxide synthesis and apoptosis by arginase and arginine recycling","volume":"137","author":"Mori","year":"2007","journal-title":"J. Nutr."},{"issue":"8\u20139","key":"10.1016\/j.bcp.2026.118533_b0285","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s000180050352","article-title":"Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization","volume":"55","author":"Boucher","year":"1999","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.bcp.2026.118533_b0290","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1172\/JCI119166","article-title":"Insulin and the arginine paradox","volume":"99","author":"Kurz","year":"1997","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.bcp.2026.118533_b0295","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pharmthera.2007.03.002","article-title":"The L-arginine paradox: importance of the L-arginine\/asymmetrical dimethylarginine ratio","volume":"114","author":"Bode-B\u00f6ger","year":"2007","journal-title":"Pharmacol. Ther."},{"issue":"Pt 12","key":"10.1016\/j.bcp.2026.118533_b0300","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1242\/jeb.00361","article-title":"The caveolar nitric oxide synthase\/arginine regeneration system for NO production in endothelial cells","volume":"206","author":"Solomonson","year":"2003","journal-title":"J. Exp. Biol."},{"issue":"50","key":"10.1016\/j.bcp.2026.118533_b0305","doi-asserted-by":"crossref","first-page":"31213","DOI":"10.1074\/jbc.272.50.31213","article-title":"A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the \u201carginine paradox\u201d","volume":"272","author":"McDonald","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2026.118533_b0500","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S0022-3565(24)35048-7","article-title":"Biochemical and functional profile of a newly developed potent and isozyme-selective arginase inhibitor","volume":"290","author":"Baggio","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2026.118533_b0490","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.abb.2010.02.004","article-title":"Inhibition of human arginase I by substrate and product analogues","volume":"496","author":"Di Costanzo","year":"2010","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bcp.2026.118533_b0495","doi-asserted-by":"crossref","first-page":"9356","DOI":"10.1021\/bi010783g","article-title":"Classical and slow-binding inhibitors of human type II arginase","volume":"40","author":"Colleluori","year":"2001","journal-title":"Biochemistry"},{"issue":"17","key":"10.1016\/j.bcp.2026.118533_b0485","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1021\/ja970285o","article-title":"The new \u03b1-amino acid N\u03c9-hydroxy-nor-L-arginine: a high-affinity inhibitor of arginase well adapted to bind to its manganese cluster","volume":"119","author":"Custot","year":"1997","journal-title":"J. Am. Chem. Soc."},{"issue":"17","key":"10.1016\/j.bcp.2026.118533_b0515","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.1016\/j.bmcl.2013.06.092","article-title":"Synthesis of quaternary \u03b1-amino acid based arginase inhibitors via the Ugi reaction","volume":"23","author":"Golebiowski","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"17","key":"10.1016\/j.bcp.2026.118533_b0520","doi-asserted-by":"crossref","first-page":"8164","DOI":"10.1021\/acs.jmedchem.9b00931","article-title":"Discovery of N-Substituted 3-Amino-4-(3-boronopropyl)pyrrolidine-3-carboxylic Acids as Highly Potent Third-Generation Inhibitors of Human Arginase I and II","volume":"62","author":"Van Zandt","year":"2019","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2026.118533_b0525","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s40425-017-0308-4","article-title":"Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment","volume":"5","author":"Steggerda","year":"2017","journal-title":"J. Immunother. Cancer"},{"issue":"4","key":"10.1016\/j.bcp.2026.118533_b0530","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/1535-7163.MCT-13-0870","article-title":"Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer","volume":"13","author":"Gross","year":"2014","journal-title":"Mol. Cancer Ther."},{"issue":"7","key":"10.1016\/j.bcp.2026.118533_b0395","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1158\/1535-7163.MCT-22-0721","article-title":"Arginase 1\/2 inhibitor OATD-02: from discovery to first-in-man setup in cancer immunotherapy","volume":"22","author":"Grzybowski","year":"2023","journal-title":"Mol. Cancer Ther."},{"issue":"Suppl 2","key":"10.1016\/j.bcp.2026.118533_b0550","first-page":"A415","article-title":"OATD-02, an orally bioavailable, potent dual arginase 1\/2 inhibitor with excellent intracellular activity, enhances antitumor immunity","volume":"9","author":"Grzybowski","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"7","key":"10.1016\/j.bcp.2026.118533_b0560","first-page":"647","article-title":"Investigation of mammal arginase inhibitory properties of natural ubiquitous polyphenols by using an optimized colorimetric microplate assay","volume":"83","author":"Bordage","year":"2017","journal-title":"Planta Med."},{"issue":"6","key":"10.1016\/j.bcp.2026.118533_b0565","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1248\/cpb.c24-00240","article-title":"Threeneo-Clerodane Diterpenoids fromTinospora cordifoliaStems and their Arginase Inhibitory Activities","volume":"72","author":"Hoang","year":"2024","journal-title":"Chem. Pharm. Bull."},{"issue":"Pt 1","key":"10.1016\/j.bcp.2026.118533_b0310","first-page":"1","article-title":"Arginine metabolism: nitric oxide and beyond","volume":"336","author":"Wu","year":"1998","journal-title":"Biochem. J"},{"issue":"3\u20134","key":"10.1016\/j.bcp.2026.118533_b0315","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.niox.2007.07.001","article-title":"Endothelial nitric oxide production is tightly coupled to the citrulline-NO cycle","volume":"17","author":"Flam","year":"2007","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.bcp.2026.118533_b0320","series-title":"L-Arginine in Clinical Nutrition","first-page":"105","article-title":"Arginine, citrulline, and the citrulline-NO cycle in endothelial nitric oxide production","author":"Goodwin","year":"2016"},{"issue":"29","key":"10.1016\/j.bcp.2026.118533_b0325","doi-asserted-by":"crossref","first-page":"30349","DOI":"10.1074\/jbc.M402155200","article-title":"Targeting of endothelial nitric-oxide synthase to the cytoplasmic face of the Golgi complex or plasma membrane regulates Akt- versus calcium-dependent mechanisms for nitric oxide release","volume":"279","author":"Fulton","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2026.118533_b0330","doi-asserted-by":"crossref","first-page":"H651","DOI":"10.1152\/ajpheart.00755.2012","article-title":"Insights into the arginine paradox: evidence against the importance of subcellular location of arginase and eNOS","volume":"305","author":"Elms","year":"2013","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"key":"10.1016\/j.bcp.2026.118533_b0335","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.niox.2022.09.002","article-title":"There is no direct competition between arginase and nitric oxide synthase for the common substrate l-arginine","volume":"129","author":"Momma","year":"2022","journal-title":"Nitric Oxide"},{"issue":"12","key":"10.1016\/j.bcp.2026.118533_b0340","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41577-021-00541-y","article-title":"Metabolic barriers to cancer immunotherapy","volume":"21","author":"DePeaux","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118533_b0345","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41568-019-0106-z","article-title":"Immune control by amino acid catabolism: a new paradigm for tumor therapy","volume":"19","author":"Lemos","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcp.2026.118533_b0350","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1600-065X.2008.00608.x","article-title":"Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives","volume":"222","author":"Rodriguez","year":"2008","journal-title":"Immunol. Rev."},{"issue":"16","key":"10.1016\/j.bcp.2026.118533_b0355","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1158\/0008-5472.CAN-04-0465","article-title":"Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses","volume":"64","author":"Rodriguez","year":"2004","journal-title":"Cancer Res."},{"issue":"24","key":"10.1016\/j.bcp.2026.118533_b0360","article-title":"Mitochondrial arginase-2 is a cell-autonomous regulator of CD8+ T cell function and antitumor efficacy","volume":"4","author":"Mart\u00ed i L\u00edndez, A. A., Dunand-Sauthier, I., Conti, M.","year":"2019","journal-title":"JCI Insight"},{"issue":"24","key":"10.1016\/j.bcp.2026.118533_b0365","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.129756","article-title":"Regulatory T cells use arginase 2 to enhance their metabolic fitness in tissues","volume":"4","author":"Lowe","year":"2019","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.bcp.2026.118533_b0370","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","article-title":"L-arginine modulates T cell metabolism and enhances survival and anti-tumor activity","volume":"167","author":"Geiger","year":"2016","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.bcp.2026.118533_b0375","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nri1668","article-title":"Regulation of immune responses by L-arginine metabolism","volume":"5","author":"Bronte","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bcp.2026.118533_b0380","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.coph.2017.05.002","article-title":"The immune regulation in cancer by the amino acid metabolizing enzymes ARG and IDO","volume":"35","author":"Mondanelli","year":"2017","journal-title":"Curr. Opin. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118533_b0385","article-title":"Arginase-2-specific cytotoxic T cells specifically recognize functional regulatory T cells","volume":"9","author":"Martinenaite","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2026.118533_b0390","article-title":"Arginase-2 specific CD8+ T cells react toward malignant and regulatory cells","volume":"13","author":"Lisle","year":"2024","journal-title":"Oncoimmunology"},{"issue":"8","key":"10.1016\/j.bcp.2026.118533_b0400","article-title":"OATD-02 validates the benefits of pharmacological inhibition of arginase 1 and 2 in cancer","volume":"10","author":"Borek","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bcp.2026.118533_b0405","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3389\/fimmu.2013.00219","article-title":"Arginase 1 mediates increased blood pressure and contributes to vascular endothelial dysfunction in deoxycorticosterone acetate-salt hypertension","volume":"4","author":"Toque","year":"2013","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118533_b0410","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/CH-2012-1617","article-title":"Increased arginase levels in heart failure represent a therapeutic target to rescue microvascular perfusion","volume":"54","author":"Quitter","year":"2013","journal-title":"Clin. Hemorheol. Microcirc."},{"issue":"1\u20133","key":"10.1016\/j.bcp.2026.118533_b0415","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejphar.2013.04.044","article-title":"Arginase inhibition reduces infarct size via nitric oxide, protein kinase C epsilon and mitochondrial ATP-dependent K+ channels","volume":"712","author":"Tratsiakovich","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"25","key":"10.1016\/j.bcp.2026.118533_b0420","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1161\/CIRCULATIONAHA.112.140335","article-title":"Arginase inhibition improves endothelial function in patients with coronary artery disease and type 2 diabetes mellitus","volume":"126","author":"Shemyakin","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2026.118533_b0425","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3389\/fimmu.2014.00533","article-title":"Functions of arginase isoforms in macrophage inflammatory responses: impact on cardiovascular diseases and metabolic disorders","volume":"5","author":"Yang","year":"2014","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118533_b0430","first-page":"12","article-title":"Stable expression of human arginase 1 does not suppress inflammation or M1 macrophage polarization in THP-1 monocytes","volume":"31","author":"Li","year":"2025","journal-title":"Mol. Med. Rep."},{"issue":"15","key":"10.1016\/j.bcp.2026.118533_b0435","article-title":"Macrophage-fibroblast crosstalk drives Arg1-dependent lung fibrosis via ornithine loading","volume":"134","author":"O'Dwyer","year":"2024","journal-title":"J. Clin. Investig."},{"issue":"617","key":"10.1016\/j.bcp.2026.118533_b0440","article-title":"Extracellular PKM2 facilitates organ-tissue fibrosis progression","volume":"13","author":"Yang","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.bcp.2026.118533_b0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000371","article-title":"Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis","volume":"5","author":"Pesce","year":"2009","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.bcp.2026.118533_b0450","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00210-008-0286-7","article-title":"Arginase and pulmonary diseases","volume":"378","author":"Maarsingh","year":"2008","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118533_b0455","article-title":"Dysregulation of arginase and arginine pathways in neurodegenerative diseases: metabolic and cellular dysfunction and therapeutic implications","volume":"94","author":"Polis","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"3","key":"10.1016\/j.bcp.2026.118533_b0460","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3233\/JAD-2010-100630","article-title":"Is the urea cycle involved in Alzheimer's disease?","volume":"21","author":"Hansmannel","year":"2010","journal-title":"J. Alzheimers Dis."},{"issue":"9","key":"10.1016\/j.bcp.2026.118533_b0465","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.neurobiolaging.2014.03.013","article-title":"Altered arginine metabolism in Alzheimer's disease brains","volume":"35","author":"Liu","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"15","key":"10.1016\/j.bcp.2026.118533_b0470","doi-asserted-by":"crossref","first-page":"5969","DOI":"10.1523\/JNEUROSCI.4668-14.2015","article-title":"Arginine deprivation and immune suppression in a mouse model of Alzheimer's disease","volume":"35","author":"Kan","year":"2015","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.bcp.2026.118533_b0475","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/s13311-018-0669-5","article-title":"L-Norvaline reverses cognitive decline and synaptic loss in a murine model of Alzheimer's disease","volume":"15","author":"Polis","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"4","key":"10.1016\/j.bcp.2026.118533_b0480","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/s13311-018-0669-5","article-title":"Can arginase inhibitors be the answer to therapeutic challenges in Alzheimer's disease?","volume":"15","author":"Polis","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bcp.2026.118533_b0505","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1016\/j.bmc.2005.01.053","article-title":"Synthesis and evaluation of new \u03c9-borono-\u03b1-amino acids as rat liver arginase inhibitors","volume":"13","author":"Busnel","year":"2005","journal-title":"Bioorg. Med. Chem."},{"issue":"9","key":"10.1016\/j.bcp.2026.118533_b0510","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1021\/bi002317h","article-title":"Probing erectile function: S-(2-boronoethyl)-L-cysteine binds to arginase as a transition state analogue and enhances smooth muscle relaxation in human penile corpus cavernosum","volume":"40","author":"Kim","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2026.118533_b0535","article-title":"Structural insights into human Arginase-1 pH dependence and its inhibition by the small molecule inhibitor CB-1158","volume":"4","author":"Grobben","year":"2019","journal-title":"Journal of Structural Biology: X"},{"key":"10.1016\/j.bcp.2026.118533_b0540","first-page":"3005","article-title":"Phase I study of the arginase inhibitor INCB001158 as a single agent and in combination with pembrolizumab in patients with advanced\/metastatic solid tumors","volume":"37","author":"Papadopoulos","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bcp.2026.118533_b0545","first-page":"P257","article-title":"Phase I study of the arginase inhibitor INCB001158 alone and in combination with pembrolizumab in patients with advanced\/metastatic solid tumors","volume":"7","author":"Naing","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bcp.2026.118533_b0555","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.3390\/cancers14163967","article-title":"OATD-02 Validates the Benefits of Pharmacological Inhibition of Arginase 1 and 2 in Cancer","volume":"14","author":"Grzybowski","year":"2022","journal-title":"Cancers"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226008750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226008750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:45:38Z","timestamp":1792017938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226008750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":113,"alternative-id":["S0006295226008750"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118533","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isoform differentiation studies of arginase: From structural function to design strategies for specific ligands and their application prospects","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118533","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118533"}}